Management and outcome in 75 individuals with long-chain fatty acid oxidation defects: Results from a workshop

Journal of Inherited Metabolic Disease

Volumn 32, Issue 4, 2009, Pages 488-497

  Spiekerkoetter, U ^a   Lindner, M ^b   Santer, R ^c   Grotzke, M ^a   Baumgartner, M R ^d   Boehles, H ^e   Das, A ^f   Haase, C ^g   Hennermann, J B ^h   Karall, D ⁱ   de Klerk, H ^j   Knerr, I ^k   Koch, H G ^l   Plecko, B ^m   Roschinger W ⁿ   Schwab, K O ^o   Scheible, D ^p   Wijburg, F A ^q   Zschocke, J ^r   Mayatepek, E ^a   Wendel, U ^a   more..

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^d UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^e UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^f Depts Pediat Hematol and Oncology   (Germany)

^g JENA UNIVERSITY HOSPITAL   (Germany)

^h CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

ⁱ ST ANNA CHILDREN S HOSPITAL   (Austria)

^j ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^k UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^l UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^m Universitatsklinik fur Kinder und Jugendheilkunde Graz   (Austria)

ⁿ LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^o UNIVERSITY OF FREIBURG   (Germany)

^p Children's Hospital   (Germany)

^q UNIVERSITY OF AMSTERDAM   (Netherlands)

^r INNSBRUCK MEDICAL UNIVERSITY   (Austria)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACETYL COENZYME A ACYLTRANSFERASE; ACYL COENZYME A DEHYDROGENASE; BASIC F; CARNITINE; CARNITINE PALMITOYLTRANSFERASE I; DOCOSAHEXAENOIC ACID; ESSENTIAL FATTY ACID; FATTY ACID DERIVATIVE; LONG CHAIN ACYL COENZYME A DEHYDROGENASE; LONG CHAIN FATTY ACID; MEDIUM CHAIN TRIACYLGLYCEROL; MITOCHONDRIAL PROTEIN; MONOGEN; TRACE ELEMENT; UNCLASSIFIED DRUG; VERY LONG CHAIN FATTY ACID;

AGE DISTRIBUTION; ARTICLE; ARTIFICIAL MILK; BREAST MILK; CARDIOMYOPATHY; CHILD; CONSANGUINITY; DIET SUPPLEMENTATION; DIET THERAPY; DIETARY INTAKE; ESSENTIAL FATTY ACID DEFICIENCY; FATTY ACID OXIDATION; FATTY LIVER; FEMALE; HELLP SYNDROME; HEPATOMEGALY; HUMAN; HYPOGLYCEMIA; LIVER DISEASE; MAJOR CLINICAL STUDY; MUSCLE HYPOTONIA; MUSCLE WEAKNESS; MYOPATHY; NEUROPATHY; NEWBORN SCREENING; NOSE FEEDING; OUTCOME ASSESSMENT; PERIPHERAL NEUROPATHY; PHENOTYPE; PRESCHOOL CHILD; RETINOPATHY; REYE SYNDROME;

ACYL-COA DEHYDROGENASE, LONG-CHAIN; ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; CONGRESSES AS TOPIC; FATTY ACIDS; FOLLOW-UP STUDIES; HUMANS; INFANT; INFANT, NEWBORN; LIPID METABOLISM, INBORN ERRORS; MIDDLE AGED; NEONATAL SCREENING; OXIDATION-REDUCTION; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 69449095345     PISSN: 01418955     EISSN: 15732665     Source Type: Journal    
DOI: 10.1007/s10545-009-1125-9     Document Type: Article

References (22)

1. Andresen BS, Olpin S, Poorthuis BJ, et al (1999) Clear correlation of genotype with disease phenotype in very long-chain acyl-CoA dehydrogenase deficiency. Am J Hum Genet 64:479-494. doi: 10.1086/302261
2. Das AM, Illsinger S, Lucke T, et al (2006) Isolated mitochondrial long-chain ketoacyl-CoA thiolase deficiency resulting from mutations in the HADHB gene. Clin Chem 52: 530-534. doi: 10.1373/clinchem.2005.062000
3. den Boer ME, Wanders RJ, Morris AA, Ijlst L, Heymans HS, Wijburg FA (2002) Long-chain 3-hydoxyacyl-CoA dehydrogenase deficiency: Clinical presentation and follow-up of 50 patients. Pediatrics 109: 99-104. doi: 10.1542/peds.109.1.99
4. den Boer ME, Dionisi-Vici C, Chakrapani A, van Thuijl AO, Wanders RJ, Wijburg FA (2003) Mitochondrial trifunctional protein deficiency: A severe fatty acid oxidation disorder with cardiac and neurologic involvement. J Pediatr 142: 684-689. doi: 10.1067/mpd.2003.231
5. German/Austrian/Swiss Nutrition Societies (D-A-CH Gesellschaft für Ernährung) (2000) Die Referenzwerte für die Nährstoffzufuhr, 1st edn. Franfurt-am-Main: Umschau/Braus GmbH. ISBN 3-8295-7114-3.
6. Gillingham MB, Weleber RG, Neuringer M (2005) Effect of optimal dietary therapy upon visual function in children with long-chain 3-hydroxyacyl CoA dehydrogenase and trifunctional protein deficiency. Mol Genet Metab 86: 124-133. doi: 10.1016/j.ymgme.2005.06.001
7. Gillingham MB, Scott B, Elliott D, Harding CO (2006) Metabolic control during exercise with and without medium-chain triglycerides (MCT) in children with long-chain 3-hydroxy acyl-CoA dehydrogenase (LCHAD) or trifunctional protein (TFP) deficiency. Mol Genet Metab 89: 58-63. doi: 10.1016/j.ymgme.2006.06.004
8. Gregersen N, Andresen BS, Corydon MJ, et al (2001) Mutation analysis in mitochondrial fatty acid oxidation defects: Exemplified by acyl-CoA dehydrogenase deficiencies, with special focus on genotype-phenotype relationship. Hum Mutat 18: 169-189. doi: 10.1002/humu.1174
9. Gregersen N, Bross P, Andresen BS, et al (2004) Genetic defects in fatty acid beta-oxidation and acyl-CoA dehydrogenases. Molecular pathogenesis and genotype-phenotype relationships. Eur J Biochem 271: 470-482. doi: 10.1046/j.1432-1033.2003.03949.x
10. Ibdah JA, Tein I, Dionisi-Vici C, et al (1998) Mild trifunctional protein deficiency is associated with progressive neuropathy and myopathy and suggests a novel genotype-phenotype correlation. J Clin Invest 102: 1193-1199. doi: 10.1172/JCI2091
11. Liebig M, Gyenes M, Brauers G, et al (2006) Carnitine supplementation induces long-chain acylcarnitine production-studies in the VLCAD-deficient mouse. J Inherit Metab Dis 29: 343-444. doi: 10.1007/ s10545-006-0249-4
12. Ørngreen MC, Nørgaard MG, Sacchetti M, van Engelen BG, Vissing J (2004) Fuel utilization in patients with very long-chain acyl-coa dehydrogenase deficiency. Ann Neurol 56: 279-283. doi: 10.1002/ ana.20168
13. Primassin S, Ter Veld F, Mayatepek E, Spiekerkoetter U (2008) Carnitine supplementation induces acylcarnitine production in tissues of very long-chain acyl-CoA dehydrogenase-deficient mice, without replenishing low free carnitine. Pediatr Res 63: 632-637. doi: 10.1203/ PDR.0b013e31816ff6f0
14. Roe CR, Sweetman L, Roe DS, David F, Brunengraber H (2002) Treatment of cardiomyopathy and rhabdomyolysis in long-chain fat oxidation disorders using an anaplerotic odd-chain triglyceride. J Clin Invest 110:259-269.
15. Roe CR, Roe DS, Wallace M, Garritson B (2007) Choice of oils for essential fat supplements can enhance production of abnormal metabolites in fat oxidation disorders. Mol Genet Metab 92: 346-350. doi: 10.1016/ j.ymgme.2007.07.012
16. Sander J, Sander S, Steuerwald U, et al (2005) Neonatal screening for defects of the mitochondrial trifunctional protein. Mol Genet Metab 85: 108-114. doi: 10.1016/j.ymgme.2005.02.002
17. Spiekerkoetter U (2007) Effects of a fat load and exercise on asymptomatic VLCAD deficiency. J Inherit Metab Dis 30: 405. doi: 10.1007/ s10545-007-0548-4
18. Spiekerkoetter U, Sun B, Zytkovicz T, Wanders R, Strauss AW, Wendel U (2003) MS/MS-based newborn and family screening detects asymptomatic patients with very long-chain acyl-CoA dehydrogenase deficiency. J Pediatr 143: 335-342. doi: 10.1067/S0022-3476(03)00292-0
19. Spiekerkoetter U, Bennett MJ, BenZe'ev B, Strauss AW, Tein I (2004) Peripheral neuropathy, episodic myoglobinuria and respiratory failure in deficiency of the mitochondrial trifunctional protein. Muscle Nerve 29: 66-72. doi: 10.1002/mus.10500
20. Spiekerkoetter U, Ruiter J, Tokunaga C, et al (2006) Evidence for impaired gluconeogenesis in very long-chain acyl-CoA dehydrogenase -deficient mice. Horm Metab Res 38: 625-630. doi: 10.1055/s-2006-954581
21. Ushikubo S, Aoyama T, Kamijo T, et al (1996) Molecular characterization of mitochondrial trifunctional protein deficiency: Formation of the enzyme complex is important for stabilization of both α- and β-subunits. Am J Hum Genet 58: 979-988
22. Wilcken B, Wiley V, Hammond J, et al (2003) Screening newborns for inborn errors of metabolism by tandem mass spectrometry. N Engl J Med 348: 2304-2312. doi: 10.1056/NEJMoa025225